Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danzhen Toutong capsules (丹珍头痛胶囊) is a traditional Tibetan medicine marketed for the treatment of headaches, including migraines and tension headaches. Formulated with a blend of natural ingredients including Plateau Salvia (高原丹参), Prunella vulgaris (夏枯草), Rehmannia glutinosa (熟地黄), Concha Margaritifera (珍珠母), Spatholobus suberectus (鸡血藤), Ligusticum chuanxiong (川芎), Angelica sinensis (当归), Paeonia lactiflora (白芍), Chrysanthemum (菊花), Tribulus terrestris (蒺藜), Uncaria (钩藤), and Asarum (细辛), the capsules work by calming the liver, extinguishing wind, dispersing stasis, and unblocking collaterals. The product was originally developed and manufactured by Qinghai Yixin Pharmaceutical, which was acquired by Grand Beilin (Xi'an) Pharmaceutical (a subsidiary of Grand Pharmaceutical Group / China Grand Enterprises) and subsequently renamed Grand Beilin (Qinghai) Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danzhen Toutong capsules.